Dr. Aditya K. Samal, MD

Dr. Samal practices at Cardiovascular Specialists Of Willowbrook in Houston, Texas.

Dr. Samal's NPI, 1790744399, was assigned on March 22, 2006. Dr. Samal holds Texas license L5122.

Dr. Samal's primary practice is Cardiovascular Specialists of Willowbrook, at 13325 Hargrave Rd Suite 100 Suite 100, Houston, TX 77070-4540. The practice phone is (281) 469-8007.

Dr. Samal's primary practice is Cardiovascular Specialists Of Willowbrook in Houston, Texas. Dr. Samal is also affiliated with Houston Methodist Willowbrook Hospital. The medical group on file is Cardiovascular Specialists of Willowbrook.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samal practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Samal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Samal is licensed in Texas.

CMS data shows 2,264 Medicare services from Dr. Samal across 24 procedure codes in 2024, for 286 Medicare patients. Medicare paid $362,718 for them.

CMS counts 286 Medicare patients who saw Dr. Samal in 2024. The largest group is 75 to 84, with 110 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samal's median patient age at 76, with 50% women.

In 2024, Dr. Samal wrote 3,440 Medicare Part D claims for 449 patients. 79% of them were for generic drugs. CMS names the drug for 3,162 of them, across 58 drugs with 11 or more claims each, at $613,302 in total drug cost. In 2023, CMS named 3,658 claims across 61 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Samal for performance year 2024, reported as part of a group. Dr. Samal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 75 procedures of varicose vein removal by Dr. Samal, more than 80% of the clinicians it reports for that procedure.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Samal to 1 clinical trial. Conditions studied include Diabetes Mellitus, Type 2 and Diabetes Mellitus. Open Payments lists research payments to Dr. Samal that name 2 trials.

CMS Open Payments shows 665 general payments to Dr. Samal from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Abbott Laboratories paid the most, $4,337. It also lists 9 research payments totaling $117,755 from 2016 to 2024, naming 2 clinical trials.